NAFLD renaming to MAFLD, MASLD: background, similarities, differences, and countermeasures
10.3760/cma.j.cn501113-20230809-00042
- VernacularTitle:NAFLD更名MAFLD、MASLD：背景、异同、对策
- Author:
Jiangao FAN
1
;
Xiaoying LI
Author Information
1. 上海交通大学医学院附属新华医院消化内科，上海 200092
- Keywords:
Fatty liver;
Nonalcoholic;
Nomenclature;
Obesity;
Type 2 diabetes mellitus;
Metabolic syndrome
- From:
Chinese Journal of Hepatology
2023;31(8):789-792
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is a chronic metabolic stress liver injury due to chronic malnutrition in genetically susceptible individuals. With the prevalence of obesity, diabetes, and metabolic syndrome, NAFLD has become the world's number one chronic liver disease, and the flaws of forty years of exclusive disease diagnostic criteria and stigmatized disease terminology are becoming increasingly prominent. To this end, in the past three years, the international consensus group and the three major hepatology societies have suggested that NAFLD be renamed metabolism-associated fatty liver disease (MAFLD) and metabolism-associated steatosis liver disease (MASLD). Here is a description of the background of naming NAFLD, MAFLD, and MASLD, the similarities and differences of the three terms, the existing disputes, and our country’s coping strategies.
